Literature DB >> 8084597

Induction of genomic instability in SV40 transformed human cells: sufficiency of the N-terminal 147 amino acids of large T antigen and role of pRB and p53.

C Woods1, C LeFeuvre, N Stewart, S Bacchetti.   

Abstract

Genomic instability is an early event in the transformation of human cells by SV40 and may contribute, as a mutagenic process, to the generation of the rare cells which survive crisis and yield immortal populations. We have previously reported that expression of large T antigen is responsible for induction of chromosome aberrations and aneuploidy. In the present study we have demonstrated that the amino terminal 147 amino acids of the protein are as proficient as full length T antigen for this destabilization of the cell genome. Analysis of mutants within this region indicated that T antigens defective for binding to pRB or lacking the first 127 amino acids are significantly reduced in their ability to induce aneuploidy and/or aberrations, whereas a cytoplasmic T antigen is less severely impaired. In addition, we have shown that binding of T antigen to p53 is dispensable for genome destabilization but may be required for continued proliferation of genetically aberrant cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084597

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1.

Authors:  Marina Cotsiki; Rowena L Lock; Yuan Cheng; Grace L Williams; Jean Zhao; David Perera; Raimundo Freire; Alan Entwistle; Erica A Golemis; Thomas M Roberts; Parmjit S Jat; Ole V Gjoerup
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

2.  Differentiation and growth potential of human ovarian surface epithelial cells expressing temperature-sensitive SV40 T antigen.

Authors:  E H Leung; P C Leung; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

3.  Alterations of DNA damage repair pathways resulting from JCV infection.

Authors:  Armine Darbinyan; Martyn K White; Selma Akan; Sujatha Radhakrishnan; Luis Del Valle; Shohreh Amini; Kamel Khalili
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

Review 4.  The role of viral and bacterial pathogens in gastrointestinal cancer.

Authors:  Michael Selgrad; Peter Malfertheiner; Lucia Fini; Ajay Goel; C Richard Boland; Luigi Ricciardiello
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

5.  Immortalization of primary sheep embryo kidney cells.

Authors:  N Seridi; M Hamidouche; N Belmessabih; S El Kennani; J Gagnon; G Martinez; C Coutton; T Marchal; Y Chebloune
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-01-07       Impact factor: 2.416

Review 6.  Nuclear IRS-1 and cancer.

Authors:  Krzysztof Reiss; Luis Del Valle; Adam Lassak; Joanna Trojanek
Journal:  J Cell Physiol       Date:  2012-08       Impact factor: 6.384

7.  Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen.

Authors:  Sergei Boichuk; Liang Hu; Jennifer Hein; Ole V Gjoerup
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

8.  Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding.

Authors:  Jennifer Hein; Sergei Boichuk; Jiaping Wu; Yuan Cheng; Raimundo Freire; Parmjit S Jat; Thomas M Roberts; Ole V Gjoerup
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

9.  Replication stress and mitotic dysfunction in cells expressing simian virus 40 large T antigen.

Authors:  Liang Hu; Harilaos Filippakis; Haomin Huang; Timothy J Yen; Ole V Gjoerup
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

10.  High prevalence of human polyomavirus JC VP1 gene sequences in pediatric malignancies.

Authors:  B Shiramizu; N Hu; R J Frisque; V R Nerurkar
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2007-05-15       Impact factor: 1.206

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.